Conference Reports for NATAP

13th Intl Workshop on Adverse Reactions & Comorbidities in HIV 14-16 July 2011-Rome, Italy Back

Bone Mineral Density (BMD) Analysis in Antiretroviral (ART)-Naïve Subjects Taking Lopinavir/ritonavir (LPV/r) Combined with Raltegravir (RAL) or Tenofovir/Emtricitabine (TDF/FTC) for 96 weeks in the PROGRESS Study       Reported by Jules Levin 13th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV 14-16 July 2011-Rome, Italy